Target type: molecularfunction
Catalysis of the reaction: GDP + H2O = GMP + phosphate. [PMID:2989286, RHEA:22156]
GDP phosphatases are a family of enzymes that catalyze the hydrolysis of guanosine diphosphate (GDP) to guanosine monophosphate (GMP). This reaction involves the removal of a phosphate group from the beta-phosphate of GDP, leading to the formation of GMP and inorganic phosphate. GDP phosphatases play a crucial role in various cellular processes, including signal transduction, nucleotide metabolism, and protein synthesis.
In signal transduction, GDP phosphatases are involved in the inactivation of G proteins, which are essential mediators of cellular signaling pathways. G proteins are activated by the binding of GTP, and their activity is terminated by the hydrolysis of GTP to GDP by GDP phosphatases. This deactivation process ensures the proper regulation of cellular signaling events.
In nucleotide metabolism, GDP phosphatases contribute to the maintenance of nucleotide pools by converting GDP to GMP. GMP is a precursor for the synthesis of other nucleotides, including guanosine triphosphate (GTP), which is required for various cellular functions, such as protein synthesis and energy production.
GDP phosphatases also play a role in protein synthesis by modulating the activity of translation initiation factors. These factors are responsible for the initiation of protein translation, and their activity is regulated by the phosphorylation and dephosphorylation of specific amino acid residues. GDP phosphatases can dephosphorylate these residues, thereby influencing the activity of translation initiation factors and ultimately regulating protein synthesis.
In summary, GDP phosphatases are essential enzymes that catalyze the hydrolysis of GDP to GMP, a crucial reaction involved in various cellular processes, including signal transduction, nucleotide metabolism, and protein synthesis.'
"
Protein | Definition | Taxonomy |
---|---|---|
Ectonucleoside triphosphate diphosphohydrolase 1 | An ectonucleoside triphosphate diphosphohydrolase 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P49961] | Homo sapiens (human) |
Ectonucleoside triphosphate diphosphohydrolase 8 | An ectonucleoside triphosphate diphosphohydrolase 8 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q5MY95] | Homo sapiens (human) |
Ectonucleoside triphosphate diphosphohydrolase 3 | An ectonucleoside triphosphate diphosphohydrolase 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O75355] | Homo sapiens (human) |
Ectonucleoside triphosphate diphosphohydrolase 5 | A nucleoside diphosphate phosphatase ENTPD5 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O75356] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
suramin | suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years. Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties. | naphthalenesulfonic acid; phenylureas; secondary carboxamide | angiogenesis inhibitor; antinematodal drug; antineoplastic agent; apoptosis inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; GABA antagonist; GABA-gated chloride channel antagonist; purinergic receptor P2 antagonist; ryanodine receptor agonist; trypanocidal drug |
arl-67156 | 6-N,N-diethyl-beta,gamma-dibromomethylene-D-ATP: an inhibitor of ecto-ATPase | ||
chromazonarol |